Cyclic Nucleotides, Arachidonic Acid, and Polyamines in the Pathophysiology of Inflammatory Proliferative Skin Diseases
Reference72 articles.
1. Anderson, W. B., and Jaworski, C. J., 1977, Modulation of adenylate cyclase activity of fibroblasts by free fatty acids and phospholipids, Arch. Biochem. Biophys. 180: 374–383. 2. Anonymous, 1976, Cyclic AMP and dibutyryl AMP in treatment of psoriasis, Chin. Med. J. 2: 141–146. 3. Aso, K., Deneau, D. G., Krulig, L., Wilkinson, D. I., and Farber, E. M., 1975a, Epidermal synthesis of prosta-glandins and their effect on levels of cyclic adenosine 3’,5’-monophosphate, J. Invest. Dermatol. 64: 326–331. 4. Aso, K., Orenberg, E. K., and Farber, E. M., 1975b, Reduced epidermal cyclic AMP accumulation following prostaglandin stimulation: Its possible role in the pathophysiology of psoriasis, J. Invest. Dermatol. 65: 375–378. 5. Baig, M. M., and Roberts, R. M., 1973, Comparative studies on the carbohydrate-containing membrane components of normal and adenosine 3’:5’-cyclic monophosphate-treated chinese-hamster ovary cells, Biochem. J. 134: 329–339.
|
|